California § 4127.8. 4127.8. (Added by renumbering Section 4127.9 by Stats. 2017, Ch. 649, Sec. 3.)

California Statutes

§ 4127.8. — 4127.8. (Added by renumbering Section 4127.9 by Stats. 2017, Ch. 649, Sec. 3.)

California § 4127.8.

JurisdictionCalifornia

Code BPCBusiness and Professions Code - BPC

Div. 2.DIVISION 2. HEALING ARTS

Ch. 9.CHAPTER 9. Pharmacy

Art. 7.5.ARTICLE 7.5. Sterile Drug Products

This text of California § 4127.8. (4127.8. (Added by renumbering Section 4127.9 by Stats. 2017, Ch. 649, Sec. 3.)) is published on Counsel Stack Legal Research, covering California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Cal. Business and Professions Code - BPC Code § 4127.8. (2026).

Text

(a)A pharmacy licensed pursuant to Section 4127.1 or 4127.2 that issues a recall notice regarding a sterile compounded drug shall, in addition to any other duties, contact the recipient pharmacy, prescriber, or patient of the recalled drug and the board as soon as possible within 12 hours of the recall notice if both of the following apply:

(1)Use of or exposure to the recalled drug may cause serious adverse health consequences or death.

(2)The recalled drug was dispensed, or is intended for use, in this state.

(b)A recall notice issued pursuant to subdivision (a) shall be made as follows:

(1)If the recalled drug was dispensed directly to the patient, the notice shall be made to the patient.

(2)If the recalled drug was dispensed directly to the prescriber, the notice shall be made to

Free access — add to your briefcase to read the full text and ask questions with AI

(a)
A pharmacy licensed pursuant to Section 4127.1 or 4127.2 that issues a recall notice regarding a sterile compounded drug shall, in addition to any other duties, contact the recipient pharmacy, prescriber, or patient of the recalled drug and the board as soon as possible within 12 hours of the recall notice if both of the following apply:
(1)
Use of or exposure to the recalled drug may cause serious adverse health consequences or death.
(2)
The recalled drug was dispensed, or is intended for use, in this state.
(b)
A recall notice issued pursuant to subdivision (a) shall be made as follows:
(1)
If the recalled drug was dispensed directly to the patient, the notice shall be made to the patient.
(2)
If the recalled drug was dispensed directly to the prescriber, the notice shall be made to the prescriber, who shall ensure the patient is notified.
(3)
If the recalled drug was dispensed directly to a pharmacy, the notice shall be made to the pharmacy, who shall notify the prescriber or patient, as appropriate. If the pharmacy notifies the prescriber, the prescriber shall ensure the patient is notified.